The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

Vertex Pharmaceuticals (VRTX) stock gains as England opts to reimburse its CRSPR (CRSP)-partnered gene therapy Casgevy to ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.